Observational Study
Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Apr 19, 2022; 12(4): 603-614
Published online Apr 19, 2022. doi: 10.5498/wjp.v12.i4.603
Table 1 Corresponding items between premenstrual symptoms screening tool and the Mini-premenstrual dysphoric disorder
Symptom PSST MINI-U Anger/irritability 1 U3 - D Anxiety/tension 2 U3 - B Tearful/sensitive to rejection 3 U3 - C Depressed mood /hopelessness 4 U3 - A Decreased interest in work activities 5 U3 - E Decreased interest in home activities 6 U3 - E Decreased interest in social activities 7 U3 - E Difficulty concentrating 8 U3 - F Fatigue/lack of energy 9 U3 - G Overeating/food cravings 10 U3 - H Insomnia 11 U3 - I Hypersomnia 12 U3 - I Feeling overwhelmed or out of control 13 U3 - J Physical symptoms 14 U3 - K Symptoms interfered with: Work efficiency/productivity A U2 Relationship with co-workers B U2 Relationship with family C U2 Your social life activities D U2 Home responsibilities E U2 Most menstrual periods of last year are preceded by significant mood changes for almost one week - U1
Table 2 Sociodemographic characteristics
Variables Mean age (SD), yr 32.12 (8.26) Country born, n (%) Qatar 111 (62.0) Other 68 (38.0) Marital status, n (%) Married 112 (62.6) Never married 55 (30.7) Divorced/widowed 12 (6.7) Education level, n (%) Elementary or intermediate school 11 (6.2) Secondary or high school 53 (29.9) Vocational/associate degree 55 (31.1) University degree or postgraduate degree 58 (32.7) Employment status, n (%) Employed 118 (66.6) Housewife 25 (14.1) Jobseeker 11 (6.2) Student 15 (8.5) Retired 2 (1.1) Other 6 (3.4) Lifestyle, n (%) Current cigarettes smoker 5 (2.8) Current shisha smoker 9 (5.1) Regular exercise 55 (30.7)
Table 3 Clinical features of subjects
Medical Characteristics, n (%) PMS, according to PSST 63 (35.2) PMDD according to PSST 25 (13.9) PMDD according to MINI 84 (46.7) Previous diagnoses Psychiatric diagnosis 6 (3.3) Depression 9 (5.0) Chronic lung disease 25 (13.9) Hypertension 7 (3.9) Cardiac disease 5 (2.8) Arthritis 20 (11.1) Osteoporosis 9 (5.0) Kidney disease 4 (2.2) Diabetes 10 (5.6) Hypercholesterolemia 20 (11.1) Cancer 2 (1.1) Allergies 52 (28.9)
Table 4 Frequency of symptoms as per the Mini international neuropsychiatric interview, module U and premenstrual symptoms screening tool
MINI-U (Yes) Not at all Mild Moderate Severe PSST symptoms n (%) n (%) n (%) n (%) n (%) Anger/irritability 132 (73.3) 23 (12.8) 38 (21.2) 62 (34.6) 56 (31.3) Anxiety/tension 98 (54.4) 57 (32.0) 46 (25.8) 46 (25.8) 29 (16.3) Tearful/sensitive to rejection 97 (53.9) 83 (46.6) 26 (14.6) 32 (18.0) 37 (20.8) Depressed mood/hopelessness 104 (57.8) 78 (43.8) 40 (22.5) 35 (19.7) 25 (14.0) Decreased interest in work activities 83 (46.1)(All three) 65 (36.3) 52 (29.1) 41 (22.9) 21 (11.7) Decreased interest in home activities 53 (29.8) 55 (30.9) 44 (24.7) 26 (14.6) Decreased interest in social activities 79 (44.1) 49 (27.4) 30 (16.7) 21 (11.7) Difficulty concentrating 57 (31.7) 96 (53.6) 53 (29.6) 21 (11.7) 9 (5.0) Fatigue/lack of energy 134 (74.4) 47 (26.9) 56 (32.0) 48 (27.4) 24 (13.7) Overeating/food cravings 98 (54.4) 92 (51.7) 27 (15.2) 25 (14.0) 34 (19.1) Insomnia 95 (52.8)(Both) 104 (58.4) 36 (20.2) 21 (11.8) 17 (9.6) Hypersomnia (needing more sleep) 76 (42.7) 39 (21.9) 33 (18.5) 30 (16.9) Feeling overwhelmed or out of control 66 (36.7) 101 (57.4) 22 (12.5) 37 (21.0) 16 (9.1) Physical symptoms 156 (86.7) 16 (9.0) 56 (31.5) 65 (36.5) 41 (23.0) Symptoms interfered with: A - Work efficiency/productivity 94 (52.2)(Altogether) 85 (47.8) 45 (25.3) 35 (19.7) 13 (7.3) B - Relationship with co-workers 108 (61.4) 41 (23.3) 19 (10.8) 8 (4.5) C - Relationship with family 69 (38.8) 57 (32.0) 36 (20.2) 16 (9.0) D - Your social life activities 89 (50.0) 49 (27.5) 29 (16.3) 11 (6.2) E - Home responsibilities 89 (50.0) 55 (30.9) 23 (12.9) 11 (6.2)
Table 5 Scores on Premenstrual Symptoms screening tool items by the Mini international neuropsychiatric interview, module U dichotomous responses
MINI-U No Yes PSST Median IQR Median IQR P value1 Anger/irritability 2 2 3 1 < 0.001 Anxiety/tension 2 1 3 2 < 0.001 Tearful/sensitive to rejection 1 0 3 2 < 0.001 Depressed mood/hopelessness 1 1 2 2 < 0.001 Decreased interest in work activities 1 1 3 1 < 0.001 Decreased interest in home activities 2 1 3 1 < 0.001 Decreased interest in social activities 1 1 3 1 < 0.001 Difficulty concentrating 1 1 2 1 < 0.001 Fatigue/lack of energy 1 1 2 1 < 0.001 Overeating/food cravings 1 1 2 2 < 0.001 Insomnia 1 1 1.5 2 0.004 Hypersomnia (needing more sleep) 1 1 3 3 < 0.001 Feeling overwhelmed or out of control 1 1 3 2 < 0.001 Physical symptoms 2 2 3 2 < 0.001 Symptoms interfered with: Work efficiency/productivity 1 1 2 2 < 0.001 Relationship with co-workers 1 0 2 2 < 0.001 Relationship with family 1 1 2 1 < 0.001 Your social life activities 1 1 2 2 < 0.001 Home responsibilities 1 1 2 2 < 0.001
Table 6 The cut-off scores of the Premenstrual Symptoms screening tool items with the corresponding the Mini international neuropsychiatric interview, module U items
Symptom PSST MINI-U AUC 95%CI J Cut-off Sensitivity Specificity Anger/irritability 1 U3 - D 0.804a (0.73-0.88) 0.48 2.5 0.780 0.696 Anxiety/tension 2 U3 - B 0.740a (0.67-0.81) 0.41 2.5 0.608 0.800 Tearful/sensitive to rejection 3 U3 - C 0.835a (0.77-0.90) 0.63 1.5 0.814 0.812 Depressed mood/hopelessness 4 U3 - A 0.735a (0.66-0.81) 0.38 1.5 0.718 0.658 Decreased interest in work activities 5 U3 - E 0.752a (0.68-0.83) 0.45 2.5 0.590 0.860 Decreased interest in home activities 6 U3 - E 0.743a (0.67-0.82) 0.39 2.5 0.602 0.783 Decreased interest in social activities 7 U3 - E 0.768a (0.70-0.84) 0.43 1.5 0.795 0.634 Difficulty concentrating 8 U3 - F 0.806a (0.74-0.88) 0.55 1.5 0.842 0.706 Fatigue/lack of energy 9 U3 - G 0.728a (0.64-0.81) 0.36 1.5 0.823 0.535 Overeating/food cravings 10 U3 - H 0.700a (0.62-0.78) 0.36 2.5 0.495 0.861 Insomnia 11 U3 - I 0.614a (0.530.70) 0.17 1.5 0.500 0.671 Hypersomnia 12 U3 - I 0.732a (0.66 0.81) 0.39 2.5 0.537 0.852 Feeling overwhelmed or out of control 13 U3 - J 0.714a (0.63 0.80) 0.39 1.5 0.667 0.722 Physical symptoms 14 U3 - K 0.723a (0.60 0.85) 0.33 2.5 0.643 0.682 Symptoms interfered with: Work efficiency/productivity A U2 0.696a (0.62 0.77) 0.32 1.5 0.677 0.639 Relationship with co-workers B U2 0.674a (0.60 0.75) 0.30 1.5 0.527 0.771 Relationship with family C U2 0.686a (0.61 0.76) 0.30 1.5 0.753 0.542 Your social life activities D U2 0.729a (0.65 0.80) 0.38 1.5 0.677 0.699 Home responsibilities E U2 0.724a (0.65 0.80) 0.40 1.5 0.688 0.711